American Century Companies Inc. Decreases Stock Holdings in CVS Health Corporation $CVS

American Century Companies Inc. decreased its stake in CVS Health Corporation (NYSE:CVS) by 35.8% in the second quarter, Holdings Channel.com reports. The firm owned 405,046 shares of the pharmacy operator’s stock after selling 225,537 shares during the period. American Century Companies Inc.’s holdings in CVS Health were worth $27,940,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CVS. Avion Wealth raised its position in CVS Health by 99.0% during the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 189 shares in the last quarter. Harbor Asset Planning Inc. bought a new stake in shares of CVS Health in the second quarter valued at about $30,000. Bell Investment Advisors Inc lifted its stake in CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 248 shares during the period. Roxbury Financial LLC grew its holdings in CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 202 shares in the last quarter. Finally, ORG Partners LLC lifted its holdings in CVS Health by 418.9% during the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 377 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Stock Up 0.2%

CVS stock opened at $80.03 on Monday. The company has a current ratio of 0.83, a quick ratio of 0.62 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $85.15. The stock has a market cap of $101.60 billion, a P/E ratio of 210.62, a PEG ratio of 0.87 and a beta of 0.60. The company’s 50 day moving average is $78.64 and its two-hundred day moving average is $70.84.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.24. The business had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The business’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Research analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s payout ratio is currently 700.00%.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. Robert W. Baird raised CVS Health from a “neutral” rating to an “outperform” rating and raised their price target for the stock from $71.00 to $82.00 in a report on Thursday, August 14th. UBS Group raised their target price on CVS Health from $79.00 to $96.00 and gave the company a “buy” rating in a research report on Friday, October 24th. The Goldman Sachs Group began coverage on CVS Health in a research note on Tuesday, October 14th. They set a “buy” rating and a $91.00 target price for the company. Sanford C. Bernstein raised their price target on shares of CVS Health from $72.00 to $77.00 and gave the company a “market perform” rating in a research note on Friday, September 5th. Finally, Cantor Fitzgerald lifted their price target on CVS Health from $78.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, October 30th. Two research analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $89.41.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.